BIOMARKERS &
TRIAL INNOVATION
Roberta Alexander
2026 Design and Management of
Cancer Clinical Trials Course
Distributed by:
RA

Issued to

Roberta Alexander

Want to report a typo or a mistake?

Credential Verification

Issue date: September 29, 2026

ID: effb2777-5dbe-4037-a82d-59d02f951fb1

Sylvester Comprehensive Cancer Center logo

Issued by

Sylvester Comprehensive Cancer Center

The University of Miami Sylvester Comprehensive Cancer Center is the only National Cancer Institute-designated cancer center in South Florida and is known as South Florida’s leader in patient-focused cancer research and care.

Type

Course

Format

Online

Description

The Sylvester Design and Management of Cancer Clinical Trials Course provides key information to advance translational clinical research, foster better clinical trial design, and ultimately improve patient care. Clinical research education works best when people learn together—not in silos. This course brings the full research team together, including PIs, advanced practice providers, nurses, clinical research coordinators, regulatory and lab staff, other clinical research professionals, PhD scientists, and trainees at all levels. Participants gain a strong foundation in cancer clinical research, and by learning in a shared virtual environment, attendees build common understanding, strengthen teamwork, and become better equipped to collaborate for clinical trial success. Holders of this badge learned: how to craft a letter of intent that presents the proposed research in a focused, concise manner; what emerging advances in biomarker development, bioinformatics, and liquid biopsies mean for the future of clinical trials; and why clinical trials become more informative when molecular measurement, computation, and treatment are treated as one integrated system.

Skills

Clinical Research

Cancer Clinical Trials

Biomarkers

Bioinformatics

LOI Development

Precision Medicine

Earning Criteria

Participation

Attended lectures on crafting a successful letter of intent, incorporating biomarkers into your clinical trial, and bioinformatics and liquid biopsies in contemporary clinical trials